However, while acute, systemic silencing of PFKFB3 ameliorated macrophage inflammation and atherosclerosis, chronic myeloid-specific inhibition of PFKFB3 did not have any effects on atherosclerosis (Tawakol et al., 2015; Tillie et al., 2021). The gene discussed is PFKFB3; the disease is atherosclerosis.